Log In

Forgot Password?
Create New Account

Loading... please wait

Abstract Details

Metastatic Acute Myeloid Leukemia Presenting as Foot Drop: A Rare Neurological Manifestation
Neuromuscular and Clinical Neurophysiology (EMG)
P11 - Poster Session 11 (5:30 PM-6:30 PM)

69 year old female with recently diagnosed acute myeloid leukemia undergoing induction chemotherapy for which neurology was consulted for progression right foot drop. Symptoms began as mild gait difficulty with decreased foot clearance on right which progressed to frank foot drop. On exam she had dorsiflexion weakness with disproportionate weakness in extension of the hallux and minimal plantar flexion weakness. There was  sensory loss isolated to the interdigital space between the hallux and second digit of the affected foot with symmetric reflexes and without radicular signs.

Initial diagnostic concern was for deep peroneal neuropathy for which MRI of the right lower extremity revealed 1) diffuse edema involving muscles at the anterior compartment of the leg, proximal peroneus longus muscle, and medial/lateral gastrocnemius, and 2) an intramedullary lesion was also detected at the posterolateral aspect at the proximal tibia and proximal fibular diaphysis.

Foot drop is a common neurological condition, but its underlying etiology can vary widely. We present an unusual case of foot drop, which revealed a surprising finding on MRI - the infiltration of acute myeloid leukemia (AML) into the peroneus longus and gastrocnemius muscles. This case demonstrates the importance of neuro-imaging to investigate progressive compressive neuropathies.
Not applicable
Patient was diagnosed with right lower extremity involvement of acute myeloid leukemia affecting the anterior compartment of the leg with compression on the deep peroneal nerve.

The infiltration of AML into skeletal muscles is a rare phenomenon, and its atypical presentation as foot drop is even more uncommon. It underscores the necessity of considering malignancy as a potential cause of suspected compressive neuropathies, especially when standard etiologies have been ruled out.

Nestor G. Beltre, MD
Dr. Beltre has nothing to disclose.
Jason H. Margolesky, MD (University of Miami School of Medicine) Dr. Margolesky has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion . The institution of Dr. Margolesky has received research support from NeuroNext.